157 related articles for article (PubMed ID: 35305385)
1. Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression.
Deng Q; Li X; Fang C; Li X; Zhang J; Xi Q; Li Y; Zhang R
Int Immunopharmacol; 2022 Jun; 107():108695. PubMed ID: 35305385
[TBL] [Abstract][Full Text] [Related]
2. Restoration of miR-340 controls pancreatic cancer cell
Xi Q; Zhang J; Yang G; Zhang L; Chen Y; Wang C; Zhang Z; Guo X; Zhao J; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yao Z; Zhang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503944
[TBL] [Abstract][Full Text] [Related]
3. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin-enriched Cordyceps militaris induces immunomodulation and tumor growth delay in mouse-derived breast cancer.
Jeong MH; Lee CM; Lee SW; Seo SY; Seo MJ; Kang BW; Jeong YK; Choi YJ; Yang KM; Jo WS
Oncol Rep; 2013 Oct; 30(4):1996-2002. PubMed ID: 23921598
[TBL] [Abstract][Full Text] [Related]
5. The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy.
Li Z; Li Y; Gao J; Fu Y; Hua P; Jing Y; Cai M; Wang H; Tong T
Life Sci; 2021 May; 273():119150. PubMed ID: 33662426
[TBL] [Abstract][Full Text] [Related]
6. Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
Stirling ER; Terabe M; Wilson AS; Kooshki M; Yamaleyeva LM; Alexander-Miller MA; Zhang W; Miller LD; Triozzi PL; Soto-Pantoja DR
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36418073
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy.
Chen L; Zheng X; Huang H; Feng C; Wu S; Chen R; Jiang H; Yuan M; Fu Y; Ying H; Zhou J; Jiang J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110786. PubMed ID: 37611443
[TBL] [Abstract][Full Text] [Related]
8. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
9. Natural cordycepin induces apoptosis and suppresses metastasis in breast cancer cells by inhibiting the Hedgehog pathway.
Liu C; Qi M; Li L; Yuan Y; Wu X; Fu J
Food Funct; 2020 Mar; 11(3):2107-2116. PubMed ID: 32163051
[TBL] [Abstract][Full Text] [Related]
10. Cordycepin remodels the tumor microenvironment of colorectal cancer by down-regulating the expression of PD-L1.
Wu S; Fang W; Chen L; Feng C; Chen R; Ying H; Zheng X; Jiang J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17567-17579. PubMed ID: 37910234
[TBL] [Abstract][Full Text] [Related]
11. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
[TBL] [Abstract][Full Text] [Related]
12. The application of HER2 and CD47 CAR-macrophage in ovarian cancer.
Chen Y; Zhu X; Liu H; Wang C; Chen Y; Wang H; Fang Y; Wu X; Xu Y; Li C; Lv X; Huang J; Han X; Li R; Hong W; Yu Z; Wei W; Tu J
J Transl Med; 2023 Sep; 21(1):654. PubMed ID: 37740183
[TBL] [Abstract][Full Text] [Related]
13. Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury.
Wei P; Wang K; Luo C; Huang Y; Misilimu D; Wen H; Jin P; Li C; Gong Y; Gao Y
J Neuroinflammation; 2021 Jun; 18(1):137. PubMed ID: 34130727
[TBL] [Abstract][Full Text] [Related]
14. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
Puro RJ; Bouchlaka MN; Hiebsch RR; Capoccia BJ; Donio MJ; Manning PT; Frazier WA; Karr RW; Pereira DS
Mol Cancer Ther; 2020 Mar; 19(3):835-846. PubMed ID: 31879362
[TBL] [Abstract][Full Text] [Related]
15. Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.
Wu ZH; Li N; Mei XF; Chen J; Wang XZ; Guo TT; Chen G; Nie L; Chen Y; Jiang MZ; Wang JT; Wang HB
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256517
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.
Tseng D; Volkmer JP; Willingham SB; Contreras-Trujillo H; Fathman JW; Fernhoff NB; Seita J; Inlay MA; Weiskopf K; Miyanishi M; Weissman IL
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11103-8. PubMed ID: 23690610
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
19. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signaling.
Li XY; Tao H; Jin C; DU ZY; Liao WF; Tang QJ; Ding K
Chin J Nat Med; 2020 May; 18(5):345-355. PubMed ID: 32451092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]